Loading...

Pacira BioSciences, Inc.

PCRX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$24.51
$-0.85(-3.35%)
U.S. Market opens in NaNh NaNm

Pacira BioSciences, Inc. (PCRX) Stock Overview

Explore Pacira BioSciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio147.57
EPS (TTM)$0.16
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$25.04
3 Months$29.63
1 Year Target$25.27

PCRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pacira BioSciences, Inc. (PCRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 147.57 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.35%
5-Day Change
1.87%
1-Month Change
5.65%
3-Month Change
18.58%
6-Month Change
12.74%
Year-to-Date (YTD) Change
-5.29%
1-Year Change
-5.73%
3-Year Change
-46.46%
5-Year Change
-62.10%
All-Time (Max) Change
249.15%

Contact Information

https://www.pacira.com
813 553 6680
5401 West Kennedy Boulevard, Tampa, FL, 33609

Company Facts

788 Employees
IPO DateFeb 3, 2011
CountryUS
Actively Trading

Frequently Asked Questions